201 related articles for article (PubMed ID: 10803464)
1. A new feature of Mpl receptor: ligand-induced transforming activity in FRE rat fibroblasts.
Challier C; Cocault L; Flon M; Pauchard M; Porteu F; Gisselbrecht S; Souyri M
Oncogene; 2000 Apr; 19(16):2033-42. PubMed ID: 10803464
[TBL] [Abstract][Full Text] [Related]
2. A novel MPL point mutation resulting in thrombopoietin-independent activation.
Abe M; Suzuki K; Inagaki O; Sassa S; Shikama H
Leukemia; 2002 Aug; 16(8):1500-6. PubMed ID: 12145691
[TBL] [Abstract][Full Text] [Related]
3. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
Tong W; Lodish HF
J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
[TBL] [Abstract][Full Text] [Related]
4. The c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc, and c-Mpl.
Drachman JG; Griffin JD; Kaushansky K
J Biol Chem; 1995 Mar; 270(10):4979-82. PubMed ID: 7534285
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
[TBL] [Abstract][Full Text] [Related]
6. A thrombopoietin receptor mutant deficient in Jak-STAT activation mediates proliferation but not differentiation in UT-7 cells.
Dorsch M; Danial NN; Rothman PB; Goff SP
Blood; 1999 Oct; 94(8):2676-85. PubMed ID: 10515871
[TBL] [Abstract][Full Text] [Related]
7. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases.
Sattler M; Durstin MA; Frank DA; Okuda K; Kaushansky K; Salgia R; Griffin JD
Exp Hematol; 1995 Aug; 23(9):1040-8. PubMed ID: 7543416
[TBL] [Abstract][Full Text] [Related]
8. Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain.
Drachman JG; Kaushansky K
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2350-5. PubMed ID: 9122198
[TBL] [Abstract][Full Text] [Related]
9. Thrombopoietin signal transduction: studies from cell lines and primary cells.
Drachman JG; Rojnuckarin P; Kaushansky K
Methods; 1999 Mar; 17(3):238-49. PubMed ID: 10080909
[TBL] [Abstract][Full Text] [Related]
10. Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer.
Onishi M; Mui AL; Morikawa Y; Cho L; Kinoshita S; Nolan GP; Gorman DM; Miyajima A; Kitamura T
Blood; 1996 Aug; 88(4):1399-406. PubMed ID: 8695859
[TBL] [Abstract][Full Text] [Related]
11. Sustained mitogen-activated protein kinase activation is induced by transforming erbB receptor complexes.
Wu CJ; Qian X; O'Rourke DM
DNA Cell Biol; 1999 Oct; 18(10):731-41. PubMed ID: 10541432
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets.
Miyakawa Y; Oda A; Druker BJ; Miyazaki H; Handa M; Ohashi H; Ikeda Y
Blood; 1996 Jan; 87(2):439-46. PubMed ID: 8555464
[TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.
Majka M; Ratajczak J; Villaire G; Kubiczek K; Marquez LA; Janowska-Wieczorek A; Ratajczak MZ
Exp Hematol; 2002 Jul; 30(7):751-60. PubMed ID: 12135673
[TBL] [Abstract][Full Text] [Related]
14. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.
Ogata A; Chauhan D; Teoh G; Treon SP; Urashima M; Schlossman RL; Anderson KC
J Immunol; 1997 Sep; 159(5):2212-21. PubMed ID: 9278309
[TBL] [Abstract][Full Text] [Related]
15. Differential signalling of NH2-terminal flag-labelled thrombopoietin receptor activated by TPO or anti-FLAG antibodies.
Millot GA; Vainchenker W; Duménil D; Svinarchuk F
Cell Signal; 2004 Mar; 16(3):355-63. PubMed ID: 14687665
[TBL] [Abstract][Full Text] [Related]
16. Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways.
Doshi PD; Giri JG; Abegg AL; Favara JP; Huynh MS; Kahn LE; Minnerly JC; Pegg LE; Villani-Price D; Siegel NR; Staten NR; Thomas JW; McKearn JP; Smith WG
Exp Hematol; 2001 Oct; 29(10):1177-84. PubMed ID: 11602319
[TBL] [Abstract][Full Text] [Related]
17. Thrombopoietin activates a STAT5-like factor in hematopoietic cells.
Pallard C; Gouilleux F; Bénit L; Cocault L; Souyri M; Levy D; Groner B; Gisselbrecht S; Dusanter-Fourt I
EMBO J; 1995 Jun; 14(12):2847-56. PubMed ID: 7796811
[TBL] [Abstract][Full Text] [Related]
18. Differentiation induced by the c-Mpl cytokine receptor is blocked by mutant Shc adaptor protein.
Hill RJ; Zozulya S; Lu YL; Hollenbach PW; Joyce-Shaikh B; Bogenberger J; Gishizky ML
Cell Growth Differ; 1996 Sep; 7(9):1125-34. PubMed ID: 8877093
[TBL] [Abstract][Full Text] [Related]
19. Stem cell factor synergistically enhances thrombopoietin-induced STAT5 signaling in megakaryocyte progenitors through JAK2 and Src kinase.
Drayer AL; Boer AK; Los EL; Esselink MT; Vellenga E
Stem Cells; 2005 Feb; 23(2):240-51. PubMed ID: 15671147
[TBL] [Abstract][Full Text] [Related]
20. Distinct regions of c-Mpl cytoplasmic domain are coupled to the JAK-STAT signal transduction pathway and Shc phosphorylation.
Gurney AL; Wong SC; Henzel WJ; de Sauvage FJ
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5292-6. PubMed ID: 7777500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
